Takahiro Aoki, Shinichiro Motohashi, & Haruhiko Koseki. (2023). Regeneration of invariant natural killer T (iNKT) cells: Application of iPSC technology for iNKT cell-targeted tumor immunotherapy. BMC.
Chicago Style (17th ed.) CitationTakahiro Aoki, Shinichiro Motohashi, and Haruhiko Koseki. Regeneration of Invariant Natural Killer T (iNKT) Cells: Application of IPSC Technology for INKT Cell-targeted Tumor Immunotherapy. BMC, 2023.
MLA (9th ed.) CitationTakahiro Aoki, et al. Regeneration of Invariant Natural Killer T (iNKT) Cells: Application of IPSC Technology for INKT Cell-targeted Tumor Immunotherapy. BMC, 2023.
Warning: These citations may not always be 100% accurate.